A NOVEL MGB PROBE-BASED ASSESSMENT OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA CARRYING NPM1 (NUCLEOPHOSMIN) EXON 12 MUTATIONS

被引：0
|
作者：
Dvorakova, D. [1 ]
Ohlidalova, D. [1 ]
Pospisilova, J. [1 ]
Lengerova, M. [1 ]
Mayer, J. [1 ]
机构：
[1] Univ Hosp Brno, Brno, Czech Republic
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0560
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [1] A novel quantitative assessment of minimal residual disease in patients with acute myeloid leukemia carrying NPM1 (nucleophosmin) exon 12 mutations
    D Dvorakova
    M Lengerova
    J Pospisilova
    I Palasek
    J Mayer
    Leukemia, 2009, 23 : 793 - 796
  • [2] A novel quantitative assessment of minimal residual disease in patients with acute myeloid leukemia carrying NPM1 (nucleophosmin) exon 12 mutations
    Dvorakova, D.
    Lengerova, M.
    Pospisilova, J.
    Palasek, I.
    Mayer, J.
    LEUKEMIA, 2009, 23 (04) : 793 - 796
  • [3] Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations
    P Gorello
    G Cazzaniga
    F Alberti
    M G Dell'Oro
    E Gottardi
    G Specchia
    G Roti
    R Rosati
    M F Martelli
    D Diverio
    F Lo Coco
    A Biondi
    G Saglio
    C Mecucci
    B Falini
    Leukemia, 2006, 20 : 1103 - 1108
  • [4] Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations
    Gorello, P.
    Cazzaniga, G.
    Alberti, F.
    Dell'Oro, M. G.
    Gottardi, E.
    Specchia, G.
    Roti, G.
    Rosati, R.
    Martelli, M. F.
    Diverio, D.
    Lo Coco, F.
    Biondi, A.
    Saglio, G.
    Mecucci, C.
    Falini, B.
    LEUKEMIA, 2006, 20 (06) : 1103 - 1108
  • [5] NPM1 exon 5 mutations in acute myeloid leukemia: Implications in diagnosis and minimal residual monitoring
    Wang, Peng
    Segal, Jeremy
    Drazer, Michael W.
    Venkataraman, Girish
    Arber, Daniel A.
    Gurbuxani, Sandeep
    EJHAEM, 2022, 3 (03): : 962 - 965
  • [6] Assessment of Minimal Residual Disease by NGS in Acute Myeloid Leukemia Patients by Monitoring FLT3 and NPM1 Mutations
    Xie, Z.
    Carson, A. R.
    McClain, V.
    Miller, J. E.
    Levis, M.
    Stenzel, T.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (02): : S10 - S10
  • [7] Significance of Nucleophosmin (NPM1) Mutations in Acute Myeloid Leukemia Patients with a Normal Karyotype
    Park, S.
    Chi, H.
    Cho, Y.
    Jang, S.
    Park, C.
    Lee, K.
    Lee, J.
    Lee, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 585 - 585
  • [8] Minimal residual disease (MRD) analysis in acute myeloid leukemia (AML) with normal karyotype carrying NPM1 gene mutations
    Agueli, C.
    La Rosa, M.
    Fabbiano, F.
    Rizzo, V
    Cascio, L.
    Cammarata, G.
    Marfia, A.
    Bica, M. G.
    Mirto, S.
    Santoro, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 169 - 169
  • [9] Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
    W-C Chou
    J-L Tang
    S-J Wu
    W Tsay
    M Yao
    S-Y Huang
    K-C Huang
    C-Y Chen
    C-F Huang
    H-F Tien
    Leukemia, 2007, 21 : 998 - 1004
  • [10] Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
    Chou, W-C
    Tang, J-L
    Wu, S-J
    Tsay, W.
    Yao, M.
    Huang, S-Y
    Huang, K-C
    Chen, C-Y
    Huang, C-F
    Tien, H-F
    LEUKEMIA, 2007, 21 (05) : 998 - 1004
12345